Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Glossary for Pregnancy-related conditions

  • 1,2-Benzisothiazolin-3-one -- fetal exposure: Experimental studies on rats indicate that the use of 1,2-Benzisothiazolin-3-one (a fungicide) during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 1,3Bix(2-chloroethyl)-1-nitrosourea -- Teratogenic Agent: Experimental studies on rats indicate that the use of 1,3Bix(2-chloroethyl)-1-nitrosourea during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 1-(3,5-Bis-trifluoromethyl phenyl)-4-methyl Thiosemicarbazide -- Teratogenic Agent: Experimental studies on rats indicate that the use of 1-(3,5-Bis-trifluoromethyl phenyl)-4-methyl Thiosemicarbazide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Acetamido-1,3,4-thiadiazole-5-(N-t-butylsulfonamide) -- Teratogenic Agent: Experimental studies on rats indicate that the use of 2-Acetamido-1,3,4-thiadiazole-5-(N-t-butylsulfonamide) during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Acetylaminofluorene -- Teratogenic Agent: Experimental studies on rats indicate that the use of 2-Acetylaminofluorene during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Amino-1,3,4-thiazole -- Teratogenic Agent: Experimental studies on chickens indicate that the use of 2-Amino-1,3,4-thiazole during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Amino-3-methylpyridine -- Teratogenic Agent: Experimental studies on mice indicate that the use of 2-Amino-3-methylpyridine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Aminoanthracene -- Teratogenic Agent: Experimental studies on mice indicate that the use of 2-Aminoanthracene during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 2-Benzenesulfonamido-5-tertiobutyl-1-thia-3,4-diazole -- Teratogenic Agent: Experimental studies indicate that the use of 2-Benzenesulfonamido-5-tertiobutyl-1-thia-3,4-diazole during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 3-Acetylpyridine -- Teratogenic Agent: Experimental studies on chicken eggs indicate that the use of 3-Acetylpyridine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 4-Amino-pteroylaspartic Acid -- Teratogenic Agent: Experimental studies on mice indicate that the use of 4-Amino-pteroylaspartic Acid during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 4-Biphenylmethanol -- Teratogenic Agent: Experimental studies on rat indicate that the use of 4-Biphenylmethanol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 4-Bis(2-chlorobenzyl aminomethyl) Cyclohexane -- Teratogenic Agent: Experimental studies on rats indicate that the use of 4-Bis(2-chlorobenzyl aminomethyl) Cyclohexane during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 5-(1-Aminoacetamido methyl)-1-(4-chloro-2-(o-chlorobenzoyl chlorobenzoyl)phenyl)-N,N-dimethyl-1H-s-trizole-3-carboxamide HCL dihydrate -- Teratogenic Agent: Experimental studies on rats indicate that the use of 5-(1-Aminoacetamido methyl)-1-(4-chloro-2-(o-chlorobenzoyl chlorobenzoyl)phenyl)-N,N-dimethyl-1H-s-trizole-3-carboxamide HCL dihydrate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 5-ASA -- Teratogenic Agent: There is strong evidence to indicate that exposure to 5-ASA during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • 5-Azacytidine -- Teratogenic Agent: Experimental studies on mice and rats indicate that the use of 5-Azacytidine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 5-Azauracil -- Teratogenic Agent: Experimental studies on chickens indicate that the use of 5-Azauracil during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • 6-Aminonicotinamide -- Teratogenic Agent: Experimental studies on chickens and mice indicate that the use of 6-Aminonicotinamide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • ACE Inhibitors -- Teratogenic Agent: There is strong evidence to indicate that the use of ACE Inhibitors during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • ACTH -- Teratogenic Agent: Experimental studies on mice indicate that the use of ACTH during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • AM-80 -- Teratogenic Agent: Experimental studies on rats indicate that the use of AM-80 during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Abamectin -- Teratogenic Agent: Experimental evidence in teratogenic studies on rats indicates that fetal exposure to Abamectin(a pesticide) increases the risk of developing a cleft palate. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Abrin -- Teratogenic Agent: Abrin is a seed extract from the jequirity pea which has caused reduced birth weight and other defects in experimental studies on rats. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Abrobit -- Teratogenic Agent: Experimental studies on rats indicate that fetal death can result from exposure to Abrobit which is an antihistamine. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Abruptio Placentae: Placental bleeding usually late in a pregnancy.
  • Acacia -- Teratogenic Agent: Experimental studies on rats indicate that consumption of Acacia during pregnancy produces no harmful effects on the developing fetus. The effect on human fetuses has not been conclusively determined.
  • Accutane -- Teratogenic Agent: There is strong evidence to indicate that the use of Accutane during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Acebutolol Hydrochloride -- Teratogenic Agent: Experimental studies on rats indicate that using Acebutolol Hydrochloride during pregnancy produces no harmful effects on the developing fetus. Acebutolol Hydrochloride is a beta blocker medication used to treat high blood pressure and abnormal heart rhythm. Other reports indicate that use in pregnant women also produces no harmful effects on the fetus.
  • Acemetacin -- Teratogenic Agent: Experimental studies on rats indicate that the use of Acemetacin (an NSAID) during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acephate -- Teratogenic Agent: Maternal exposure to acephate can result in negative consequences for the developing fetus.
  • Acetaldehyde -- Teratogenic Agent: Experimental studies on mice indicate that the use of Acetaldehyde during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetamide -- Teratogenic Agent: Experimental studies on rats indicate that the use of Acetamide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetaminophen -- Teratogenic Agent: There is strong evidence to indicate that exposure to Acetaminophen during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Acetanilide -- Teratogenic Agent: Experimental studies on mice indicate that the use of Acetanilide during pregnancy may cause reduced fertility in the offsprint. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetazolamide -- Teratogenic Agent: Experimental studies on mice, rats and rabbits indicate that the use of Acetazolamide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetoacetate -- Teratogenic Agent: Experimental studies on mice indicate that the use of Acetoacetate during pregnancy is unlikely to cause harmful effects on the fetus.
  • Acetohexamide -- Teratogenic Agent: Experimental studies on mice indicate that the use of Acetohexamide during pregnancy may cause death during the embryonic stage.
  • Acetohydroxamic Acid -- Teratogenic Agent: Experimental studies on rats and beagles indicate that the use of Acetohydroxamic Acid during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetonitrile -- Teratogenic Agent: Experimental studies on hamsters indicate that the use of Acetonitrile during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetoxymethyl-methylnitrosamine -- Teratogenic Agent: Experimental studies on rats indicate that the use of Acetoxymethyl-methylnitrosamine during pregnancy may cause harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acetozolamide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Acetozolamide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Acetylcholine -- Teratogenic Agent: Experimental studies on chicken eggs indicate that the use of Acetylcholine during pregnancy may cause various harmful effects on the fetus.
  • Acetylsalicylic Acid -- Teratogenic Agent: There is strong evidence to indicate that exposure to Acetylsalicylic Acid during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Acitretin- Teratogenic Agent: Reports indicate that the use of Acitretin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. Acitretin should not be taken by women who are pregnant or planning on becoming pregnant.
  • Acriflavine- Teratogenic Agent: Experimental studies on chickens indicate that the use of Acriflavine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acrylonitrile -- Teratogenic Agent: Experimental studies on rats and hamsters indicate that the use of Acrylonitrile during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Actinobolin Sulfate -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Actinobolin Sulfate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Actinomycin C -- Teratogenic Agent: Experimental studies on rats indicate that the use of Actinomycin C during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Actinomycin D -- Teratogenic Agent: Experimental studies on rats indicate that the use of Actinomycin D during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Acutane embryopathy: A rare disorder caused by fetal exposure to retinoids and resulting in mental and physical birth defects.
  • Acute fatty liver of pregnancy: A rare complication of pregnancy that can occur in the second half of the pregnancy. It is characterized by excessive fatty deposits in the liver which can be fatal without prompt diagnosis and treatment which involves delivering the baby as soon as possible.
  • Acyclovir -- Teratogenic Agent: There is strong evidence to indicate that exposure to Acyclovir during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Adenine -- Teratogenic Agent: Experimental studies on mice indicate that the use of Adenine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Adriamycin -- Teratogenic Agent: There is evidence to indicate that exposure to Adriamycin (a chemotherapy drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Aflatoxin B1- Teratogenic Agent: Reports indicate that the use of Aflatoxin B1 during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Afridol Blue -- Teratogenic Agent: Experimental studies on rats indicate that the use of Afridol Blue during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Agent Orange -- Teratogenic Agent: Reports indicate that the use of Agent Orange during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined and is still a controversial subject.
  • Aino Virus -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Aino Virus during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Akabane Virus -- Teratogenic Agent: Experimental studies on cattle indicate that the use of Akabane Virus during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Albendazole -- Teratogenic Agent: Experimental studies on rats indicate that the use of Albendazole during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Albuterol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Albuterol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Alclometasone -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Alclometasone during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Alcock syndrome: A nerve disorder which causes pain in the pelvic, genital and perianal areas.
  • Alcohol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Alcohol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Alcohol antenatal infection:
  • Alendronate -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Alendronate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Allen-Masters syndrome: Damage to muscle layers in the pelvis which allows the abnormally increased movement of the cervix. It often occurs after a traumatic surgical birth, induced abortion or excessive vaginal packing.
  • Allyl Alcohol -- Teratogenic Agent: Experimental studies on mice indicate that the use of Allyl Alcohol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Almokalant -- Teratogenic Agent: Experimental studies on rats indicate that the use of Almokalant during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aloe -- Teratogenic Agent: Experimental studies on rats indicate that the use of Aloe during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Alpha Carotene -- Teratogenic Agent: There is strong evidence to indicate that exposure to Alpha Carotene deficiency during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Alpha Carotene deficiency- Teratogenic Agent: There is strong evidence to indicate that exposure to Alpha Carotene deficiency during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Alprazolam -- Teratogenic Agent: There is strong evidence to indicate that exposure to Alprazolam during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Alprenolol -- Teratogenic Agent: Experimental studies on rats indicate that the use of Alprenolol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Alternariol Monomethyl Ether -- Teratogenic Agent: Experimental studies on mice indicate that the use of Alternariol Monomethyl Ether during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Amantadine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amantadine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ambroxol -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Ambroxol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Amelometasone -- Teratogenic Agent: Experimental studies on mice indicate that the use of Amelometasone during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Ametantrone Acetate -- Teratogenic Agent: Experimental studies on various animals indicate that the use of Ametantrone Acetate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Amiloride -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amiloride during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Aminoacetonitrile -- Teratogenic Agent: Experimental studies on rats indicate that the use of Aminoacetonitrile during pregnancy may cause lathyrism syndrome in the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aminoazobenzene and Derivatives -- Teratogenic Agent: Experimental studies on mice indicate that the use of Aminoazobenzene and Derivatives during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aminophyllin -- Teratogenic Agent: Experimental studies on rats indicate that the use of Aminophyllin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aminopterin -- Teratogenic Agent: There is strong evidence to indicate that exposure to ? during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Aminopterin and methotrexate -- Teratogenic Agent: There is strong evidence to indicate that the use of Aminopterin and methotrexate during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amiodarone -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amiodarone during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amitriptyline -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amitriptyline during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amlodipine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amlodipine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amnion rupture sequence: A rare disorder where the amniotic sac is ruptured resulting in various abnormalities.
  • Amniotic Bands: A rare condition where abnormal fetal development occurs when bands of tissue encircle parts of the fetus and affect the growth of that portion. The band of tissue develops from the internal womb lining. The location of the band on the fetus determines the symptoms and the seriousness of the condition.
  • Amniotic fluid syndrome: A rare disorder where large amounts of amniotic fluid suddenly enters the blood stream. The amniotic fluid contains debris which can block blood vessels and dilutes the blood which affects coagulation. This can occur when there is an opening in a blood vessel wall and can occur if the birth involves difficult labor, older women, dead fetus syndrome or large babies. The condition can result in rapid death of the mother.
  • Amobarbital -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amobarbital during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amoxicillin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amoxicillin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amphetamine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Amphetamine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amphetamines -- Teratogenic Agent: There is strong evidence to indicate that the use of Amphetamines during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ampicillin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Ampicillin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Amrubicin Hydrochloride -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Amrubicin Hydrochloride during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Anabasin Hydrochloride -- Teratogenic Agent: Experimental studies on pigs indicate that the use of Anabasin Hydrochloride during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Anagyrine -- Teratogenic Agent: Reports indicate that the use of Anagyrine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Androgens -- Teratogenic Agent: There is strong evidence to indicate that the use of Androgens during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Androstenedione -- fetal exposure: Experimental studies on rats indicate that the use of Androstenedione during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Androsterone -- fetal exposure: Experimental studies on rats indicate that the use of Androsterone during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Anemia of pregnancy: Anemia of pregnancy is anemia that occurs during pregnancy. Women's bodies have a greater demand for iron during pregnancy and if intake is not sufficient, anemia can result. Anemia in pregnant women can lead to infant problems such as premature birth, fetal death, retarded growth and other problems.
  • Angiectasis pregnancy: A rare condition that occurs during the final trimester of pregnancy and involves the development of small painful areas of raised blood vessel clusters that occur on the back of the legs.
  • Angiotensin -- Teratogenic Agent: Experimental studies on guinea pigs indicate that the use of Angiotensin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Antepartum Eclampsia: Antepartum eclampsia is the development of seizures or coma in pregnant women suffering from high blood pressure. Antepartum means that it occurs before delivery. Eclampsia is a serious condition which requires urgent medical treatment. Eclampsia may be associated with moderate as well as significant increases in blood pressure. The blood pressure can return to normal after delivery or may persist for a period of time.
  • Antithyroid drugs -- Teratogenic Agent: There is strong evidence to indicate that the use of Antithyroid drugs during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Apholate -- Teratogenic Agent: Experimental studies on lambs indicate that the use of Apholate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Apomorphine -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Apomorphine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aprotinin -- Teratogenic Agent: Experimental studies on rats indicate that the use of Aprotinin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Arotinoid Ethyl Ester -- Teratogenic Agent: Experimental studies on mice indicate that the use of Arotinoid Ethyl Ester during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Arotinolol -- fetal exposure: Experimental studies on rabbits indicate that the use of Arotinolol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Arsenate -- Teratogenic Agent: Experimental studies on mice indicate that the use of Arsenate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Arsenic -- Teratogenic Agent: Reports indicate that the use of Arsenic during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Asaline -- Teratogenic Agent: Experimental studies on rats indicate that the use of Asaline during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aspirin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Aspirin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Asthma in pregnancy: Asthma in pregnancy refers to inflammation and constriction of the airways that is occurs during pregnancy. Women who are pregnancy may decide to stop taking their asthma medication in order to reduce the perceived risk of side effects to the developing fetus. The reality is that the potential harmful effects on the fetus are very small compared to the problems caused to mother and fetus if a severe asthma attack develops. Furthermore, uncontrolled asthma during pregnancy may also cause problems such as small birth weight or premature birth. Pregnant women should consult their physician in order to determine the optimal management of their condition. During pregnancy, asthma symptoms may become worse, improve or stay the same.
  • Atenolol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Atenolol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Atorvastatin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Atorvastatin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Atropine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Atropine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Auranofin -- Teratogenic Agent: Experimental studies on rabbits indicate that the use of Auranofin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Aureomycin -- Teratogenic Agent: There is evidence to indicate that exposure to Aureomycin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Autoimmune disorders -- Teratogenic Agent: There is strong evidence to indicate that the development of autoimmune disorders during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the stage of pregnancy that the exposure occurred at.
  • Azatadine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Azatadine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Azathioprine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Azathioprine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Azithromycin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Azithromycin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • BD40A -- Teratogenic Agent: Experimental studies on rats indicate that the use of BD40A during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • BOMT -- Teratogenic Agent: Experimental studies on rats indicate that the use of BOMT during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • BRL 16644, 16657 -- Teratogenic Agent: Experimental studies or reports indicate that the use of BRL 16644, 16657 during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bacampicillin Hydrochloride -- fetal exposure: Experimental studies on rats and rabbits indicate that the use of Bacampicillin Hydrochloride during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Baclofen -- Teratogenic Agent: There is strong evidence to indicate that exposure to Baclofen during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bacterial toxins -- fetal exposure: Experimental studies on mice indicate that the use of Bacterial toxins during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Ballantyne's triad: The association of fetal hydrops, maternal edema and an enlarged placenta.
  • Ballantyne-Runge syndrome: A pregnancy that goes over the normal gestation term of 42 weeks. The greatest problem with prolonged gestation is the fact that the placenta may shrink and be unable to supply the fetus with sufficient oxygen and nutrients. In extreme cases, the fetus may lose weight or suffer problems from chronic oxygen shortage.
  • Balofloxacin -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Balofloxacin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bar's syndrome: A rare type of bacterial infection that tends to occur in pregnant women. It manifests as pain in the gallbladder, ureter or appendix area as well as fever and bacteria in the urine.
  • Barium -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Bamifylline during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Batroxobin -- fetal exposure: Experimental studies on beagle dogs and rats indicate that the use of Batroxobin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Baycol -- Teratogenic Agent: There is evidence to indicate that exposure to Baycol (a statin medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Beclomethasone -- Teratogenic Agent: There is strong evidence to indicate that exposure to Beclomethasone during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Beclomethasone Dipropionate -- Teratogenic Agent: Experimental studies on rats indicate that the use of Beclomethasone Dipropionate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Befunolol -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Befunolol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Belladona -- Teratogenic Agent: There is strong evidence to indicate that exposure to Belladona during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benadryl -- Teratogenic Agent: There is evidence to indicate that exposure to Benadryl during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benazepril -- Teratogenic Agent: There is strong evidence to indicate that exposure to Benazepril during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benazepril Hydrochloride -- Teratogenic Agent: Experimental studies on rats indicate that the use of Benazepril Hydrochloride during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bendazole -- Teratogenic Agent: Experimental studies on mice and rats indicate that the use of Bendazole during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bendectin -- Teratogenic Agent: There is evidence to indicate that exposure to Bendectin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benomyl -- Teratogenic Agent: Experimental studies on rats indicate that the use of Benomyl during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzbromarone -- Teratogenic Agent: Experimental studies on mice, rats and rabbits indicate that the use of Benzbromarone during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzene -- fetal exposure: Experimental studies indicate that the use of Benzene during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzenesulfonic Acid Hydrazide -- fetal exposure: Experimental studies on mice indicate that the use of Benzenesulfonic Acid Hydrazide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzidine -- fetal exposure: Experimental studies on mice indicate that the use of Benzidine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzimidazole -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Benzimidazole during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzo(a)pyrene and Derivatives -- Teratogenic Agent: Experimental studies on rats and mice indicate that the use of Benzo(a)pyrene and Derivatives during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzodiazepine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Benzodiazepine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benzofuranyl Ureas -- Teratogenic Agent: Experimental studies on rats indicate that the use of Benzofuranyl Ureas during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzolamide -- Teratogenic Agent: Experimental studies on rats indicate that the use of Benzolamide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzthiazide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Benzthiazide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benztropine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Benztropine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Benztropine Mesylate -- Teratogenic Agent: Reports indicate that the use of Benztropine Mesylate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzyl Alcohol -- Teratogenic Agent: Experimental studies on chickens indicate that the use of Benzyl Alcohol during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Benzyloxycarbonyl-phenylalanine-alanine-diazomethane -- fetal exposure: Experimental studies on rats indicate that the use of Benzyloxycarbonyl-phenylalanine-alanine-diazomethane during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bepridil Hydrochloride -- fetal exposure: Experimental studies on rats indicate that the use of Bepridil Hydrochloride during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Beryllium -- fetal exposure: Experimental studies on rats indicate that the use of Beryllium during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Betamethasone -- Teratogenic Agent: There is strong evidence to indicate that exposure to Betamethasone during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Betamethasone Butyrate Propionate -- Teratogenic Agent: Experimental studies on rats and rabbits indicate that the use of Betamethasone Butyrate Propionate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Betamtehasone -- Teratogenic Agent: Experimental studies on rats and mice indicate that the use of Betamtehasone during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Betaxolol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Betaxolol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Biaxin -- Teratogenic Agent: There is evidence to indicate that exposure to Biaxin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Birth Injury: An injury to the mother caused by childbirth
  • Birth asphyxia: Hypoxia during passage of birth.
  • Bis(tri-n-butyltin) Oxide -- Teratogenic Agent: Experimental studies on mice indicate that the use of Bis(tri-n-butyltin) Oxide during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bis-dichloroacetyl-amine -- Teratogenic Agent: Experimental studies on rats indicate that the use of Bis-dichloroacetyl-amine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bisdiamine -- Teratogenic Agent: Experimental studies on rats indicate that the use of Bisdiamine during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bismuth -- Teratogenic Agent: Experimental studies on sheep indicate that the use of Bismuth during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bismuth subsalicylate -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bismuth subsalicylate during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bisoprolol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bisoprolol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bisoprolol Fumarate -- fetal exposure: Experimental studies on rats and rabbits indicate that the use of Bisoprolol Fumarate during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bladder Incontinence (Pregnancy): Bladder incontinence that occurs during pregnancy
  • Blueberry muffin syndrome: A manifestation of fetal rubella infection. The newborn has purplish or bluish skin lesions or bumps as well as thrombocytopenia. The skin usually clears within 6 weeks.
  • Boric Acid -- Teratogenic Agent: Experimental studies on chickens and rabbits indicate that the use of Boric Acid during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bovine Albumin Anaphylaxis -- Teratogenic Agent: Experimental studies on mice indicate that the use of Bovine Albumin Anaphylaxis during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Bradykinin -- Teratogenic Agent: Experimental studies on mice indicate that the use of Bradykinin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Breech pregnancy: Pregnancy with fetus reversed with head up.
  • Bretylium -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bretylium during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Brevibloc -- Teratogenic Agent: There is evidence to indicate that exposure to Brevibloc (a heart drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bromides -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bromides during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bromocriptine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bromocriptine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Budesonide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Budesonide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Bumetanide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bumetanide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Buprenorphine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Buprenorphine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Busulfan -- Teratogenic Agent: There is strong evidence to indicate that exposure to Busulfan during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Butoconazole -- Teratogenic Agent: There is strong evidence to indicate that exposure to Butoconazole during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Butriptyline -- Teratogenic Agent: There is strong evidence to indicate that exposure to Butriptyline during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • CMV antenatal infection: A rare condition where a fetus becomes infected with the cytomegalovirus through the mother.
  • Caesarian Section: Surgery to deliver a fetus from the uterus.
  • Caffeine -- Teratogenic Agent: There is strong evidence to indicate that exposure to caffeine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Calcitriol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Calcitriol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Campylobacter fetus infection: Campylobacter fetus is a food borne bacterial infection which may vary in severity from mild to severe. The bacteria are opportunistic and mainly affect debilitated patients but can also occur in healthy patients. Abortion due to blood infection in the fetus can occur in pregnant women who become infected. The infection is less likely to cause gastrointestinal symptoms such as diarrhea than other Campylobacter infections but is prone to causing infection in other parts of the body such as the appendix, abdominal cavity, central nervous system (meningitis), gallbladder, urinary tract and blood stream. Cattle and sheep are the main source of this bacteria.
  • Candesartan -- Teratogenic Agent: There is strong evidence to indicate that exposure to Candesartan during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Candesartan Cilexetil -- Teratogenic Agent: There is strong evidence to indicate that exposure to Candesartan Cilexetil during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Captopril -- Teratogenic Agent: There is strong evidence to indicate that exposure to Captopril during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Carbamazepine -- Teratogenic Agent: There is strong evidence to indicate that exposure to Carbamazepine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Carbenicillin -- Teratogenic Agent: There is strong evidence to indicate that exposure to Carbenicillin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Carbimazole -- Teratogenic Agent: There is strong evidence to indicate that exposure to Carbimazole during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Carbon Monoxide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Carbon Monoxide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cardem -- Teratogenic Agent: There is evidence to indicate that exposure to Cardem (a beta-blocker medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Carisoprodol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Carisoprodol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cartelol -- Teratogenic Agent: There is strong evidence to indicate that exposure to Cartelol during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Casanthranol -- Teratogenic Agent: There is evidence to indicate that exposure to Casanthranol (a laxative) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cefachlor -- Teratogenic Agent: There is evidence to indicate that exposure to Cefachlor (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cefaclor -- Teratogenic Agent: There is evidence to indicate that exposure to Cefaclor (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cefaclorum -- Teratogenic Agent: There is evidence to indicate that exposure to Cefaclorum (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cefadroxil -- Teratogenic Agent: There is evidence to indicate that exposure to Cefadroxil (a broad spectrum antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ceftazidime -- Teratogenic Agent: There is evidence to indicate that exposure to Ceftazidime (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ceftriaxone -- Teratogenic Agent: There is evidence to indicate that exposure to Ceftriaxone (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Celexa -- Teratogenic Agent: There is evidence to indicate that exposure to Celexa (an antidepressant) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Celipro -- Teratogenic Agent: There is evidence to indicate that exposure to Celipro (a beta-blocker medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Celiprolol -- Teratogenic Agent: There is evidence to indicate that exposure to Celiprolol (a beta-blocker medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cephalexin -- Teratogenic Agent: There is evidence to indicate that exposure to Cephalexin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ceptaz -- Teratogenic Agent: There is evidence to indicate that exposure to Ceptaz (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cerivastatin -- Teratogenic Agent: There is evidence to indicate that exposure to Cerivastatin (a statin medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cetirizine -- Teratogenic Agent: There is evidence to indicate that exposure to Cetirizine (an antihistamine) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chiari-Frommel syndrome: A rare condition where galactorrhea and amenorrhea continues for an abnormal length of time (generally longer than 6 months) after giving birth.
  • Chickenpox -- Teratogenic Agent: There is strong evidence to indicate that the development of Chickenpox during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the stage of pregnancy that the exposure occurred at.
  • Childbirth: Delivery of a fetus by a pregnant woman.
  • Chlorambucil -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorambucil (a chemotherapy drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlordiazepoxide -- Teratogenic Agent: There is evidence to indicate that exposure to Chlordiazepoxide (a sedative or hypnotic drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chloroquine -- Teratogenic Agent: There is evidence to indicate that exposure to Chloroquine (an antimalarial drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlorothiazide -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorothiazide ( a diuretic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlorpheniramine -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorpheniramine (an antihistamine medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlorpromazine -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorpromazine (a neuroleptic drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlorpropamide -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorpropamide (an antidiabetic drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlortetracycline -- Teratogenic Agent: There is evidence to indicate that exposure to Chlortetracycline (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Chlorzoxazone -- Teratogenic Agent: There is evidence to indicate that exposure to Chlorzoxazone (a muscle relaxant and pain reliever) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cholestasis disease of pregnancy: A liver condition that can occur usually in the last stage of pregnancy. The flow of bile in the gallbladder or liver is impaired by the high levels of pregnancy hormones. The bile acids build up in the organs and then enter the bloodstream. The main symptom is usually itching. Symptoms usually resolve after delivering the baby. Risk factors includes existing liver condition, multiple pregnancy and a family history of the condition.
  • Cholestasis, intrahepatic of pregnancy: A rare liver disorder (impaired flow of bile) that occurs during third trimester of pregnancy with symptoms usually disappearing after delivery.
  • Cholestyramine -- Teratogenic Agent: There is evidence to indicate that exposure to Cholestyramine (cholesterol-lowering drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cholybar -- Teratogenic Agent: There is evidence to indicate that exposure to Cholybar (cholesterol-lowering drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Choriocarcinoma: Rare cancer of the placenta
  • Choriocarcinoma, infantile: A rare malignant cancer that originates in the placenta. It is an aggressive cancer which generally results in infant death.
  • Chronic Alcoholism -- Teratogenic Agent: There is strong evidence to indicate that chronic alcoholism during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ciclosporin -- Teratogenic Agent: There is evidence to indicate that exposure to Ciclosporin (an immunosuppressant drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cigarette Smoking -- Teratogenic Agent: There is strong evidence to indicate that cigarette smoking during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cimetidine -- Teratogenic Agent: There is evidence to indicate that exposure to Cimetidine (used as an antihistamine and stomach acid secretion inhibitor) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cipramil -- Teratogenic Agent: There is evidence to indicate that exposure to Cipramil (an antidepressant) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cipro -- Teratogenic Agent: There is evidence to indicate that exposure to Cipro (a fluoroquinolone antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Ciprofloxacin -- Teratogenic Agent: There is evidence to indicate that exposure to Ciprofloxacin (a fluoroquinolone antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Citalopram -- Teratogenic Agent: There is evidence to indicate that exposure to Citalopram (an antidepressant) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clarithromycin -- Teratogenic Agent: There is evidence to indicate that exposure to Clarithromycin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Classical Potter syndrome: A term that describes the physical appearance that occurs when kidney disease results in a reduced volume of amniotic fluid. In the classical type, both kidneys are absent.
  • Clavulanate potassium -- Teratogenic Agent: There is evidence to indicate that exposure to Clavulanate during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clavulanic Acid -- Teratogenic Agent: There is evidence to indicate that exposure to Clavulanic Acid during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clemastine -- Teratogenic Agent: There is evidence to indicate that exposure to Clemastine (an antihistamine) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clindamycin -- Teratogenic Agent: There is evidence to indicate that exposure to Clindamycin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clobazam -- Teratogenic Agent: There is evidence to indicate that exposure to Clobazam (an anxiolytic and anticonvulsant drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clomiphene -- Teratogenic Agent: There is evidence to indicate that exposure to Clomiphene during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clomiphene Citrate -- Teratogenic Agent: There is evidence to indicate that exposure to Clomiphene Citrate during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clomipramine -- Teratogenic Agent: There is evidence to indicate that exposure to Clomipramine (an antidepressant and anxiolytic drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clomocycline -- Teratogenic Agent: There is evidence to indicate that exposure to Clomocycline (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clonazepam -- Teratogenic Agent: There is evidence to indicate that exposure to Clonazepam during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clonidine -- Teratogenic Agent: There is evidence to indicate that exposure to Clonidine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clorazepate -- Teratogenic Agent: There is evidence to indicate that exposure to Clorazepate during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Clotrimazole -- Teratogenic Agent: There is evidence to indicate that exposure to Clotrimazole (an antifungal medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cloxacillin -- Teratogenic Agent: There is evidence to indicate that exposure to Cloxacillin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cloxapen -- Teratogenic Agent: There is evidence to indicate that exposure to Cloxapen (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cocaine -- Teratogenic Agent: There is evidence to indicate that exposure to Cocaine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cocaine fetopathy: Cocaine use during pregnancy resulting in various birth defects and other abnormalities.
  • Codeine -- Teratogenic Agent: There is evidence to indicate that exposure to Codeine (an opiate drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Colestyramine -- Teratogenic Agent: There is evidence to indicate that exposure to Colestyramine (cholesterol-lowering drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Congenital Toxoplasmosis: Fetal infection with toxoplasmosis.
  • Congenital craniosynostosis maternal hyperthyroiditis: The association of maternal thyroid disease with premature fusion of skull bones in infants. Studies have shown and increased risk of craniosynostosis in infants born to mothers with hyperthyroidism.
  • Congenital cytomegalovirus: Fetal infection with cytomegalovirus.
  • Congenital mumps: Fetal exposure to the mumps virus during pregnancy. From existing evidence, fetal exposure to mumps rarely proves to be a problem although there have been cases of spontaneous abortion and a heart condition called endocardial fibroelastosis. Infection late in the pregnancy can result in the infant contracting mumps.
  • Congenital syphilis: Syphilis inherited from mother during pregnancy.
  • Congenital tuberculosis: Fetal infection with tuberculosis
  • Congenital vaccinia: Congenital vaccinia is where the fetus becomes infected with vaccinia. This can occur when vaccination is administered during pregnancy - vaccination during the third trimester appears to be the most likely to result in fetal infection. The newborn is born with severe skin lesions and death generally occurs before or soon after birth.
  • Conjugated estrogens -- Teratogenic Agent: There is evidence to indicate that exposure to Conjugated estrogens during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Constipation: Difficult or dry bowel movements
  • Contraceptive pills -- Teratogenic Agent: There is evidence to indicate that exposure to Contraceptive pills during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cordiax -- Teratogenic Agent: There is evidence to indicate that exposure to Cordiax (a beta-blocker medication) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Corticosteroids -- Teratogenic Agent: There is evidence to indicate that exposure to Corticosteroids during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Corticotropin -- Teratogenic Agent: There is evidence to indicate that exposure to Corticotropin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cortisone -- Teratogenic Agent: There is evidence to indicate that exposure to Cortisone during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Costi -- Teratogenic Agent: There is evidence to indicate that exposure to Costi during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Coumarin Derivatives -- Teratogenic Agent: There is evidence to indicate that exposure to Coumarin Derivatives during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Crack cocaine -- Teratogenic Agent: There is evidence to indicate that exposure to Crack cocaine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Craniofacial dysostosis -- arthrogryposis -- progeroid appearence: A very rare syndrome characterized usually caused by fetal exposure to the cytomegalovirus and resulting in features such as short stature, mental retardation, joint movement problems and facial anomalies.
  • Crixan -- Teratogenic Agent: There is evidence to indicate that exposure to Crixan (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cromolyn Sodium -- Teratogenic Agent: There is evidence to indicate that exposure to Cromolyn Sodium (an asthma preventer) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cyclacillin -- Teratogenic Agent: There is evidence to indicate that exposure to Cyclacillin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cyclophosphamide -- Teratogenic Agent: There is evidence to indicate that exposure to Cyclophosphamide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cyclosporin -- Teratogenic Agent: There is evidence to indicate that exposure to Cyclosporin (an immunosuppressant drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cyclosporine -- Teratogenic Agent: There is evidence to indicate that exposure to Cyclosporine (an immunosuppressant drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cyclothiazide -- Teratogenic Agent: There is evidence to indicate that exposure to Cyclothiazide (a diuretic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cytarabine -- Teratogenic Agent: There is evidence to indicate that exposure to Cytarabine (a chemotherapy drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cytomegalovirus -- Teratogenic Agent: There is strong evidence to indicate that the development of Cytomegalovirus during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the stage of pregnancy that the exposure occurred at.
  • D-minus hemolytic uremic syndrome (D-HUS) -- pregnancy related: A rare condition characterized by hemolytic anemia, thrombocytopenia and kidney failure. This type is not associated with diarrhea and is triggered by pregnancy.
  • Danazol -- Teratogenic Agent: There is evidence to indicate that exposure to Danazol (used to treat endometriosis) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Danocrine -- Teratogenic Agent: There is evidence to indicate that exposure to Danocrine (used to treat endometriosis) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Daunomycin -- Teratogenic Agent: There is evidence to indicate that exposure to Daunomycin (a chemotherapy drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Daunorubicin -- Teratogenic Agent: There is evidence to indicate that exposure to Daunorubicin (a chemotherapy drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Debendox -- Teratogenic Agent: There is evidence to indicate that exposure to Debendox during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Declomycin -- Teratogenic Agent: There is evidence to indicate that exposure to Declomycin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Declostatin -- Teratogenic Agent: There is evidence to indicate that exposure to Declostatin (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Demeclocycline -- Teratogenic Agent: There is evidence to indicate that exposure to Demeclocycline (an antibiotic) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Depakine -- Teratogenic Agent: There is evidence to indicate that exposure to Depakine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Developmental toxicity -- 1,3-Butadiene: 1,3-Butadiene is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. 1,3-Butadiene is an industrial chemical used mainly in the production of synthetic rubber. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 1-(2-Chloroethyl)-3-Cyclohexyl-1-Nitrosourea: 1-(2-Chloroethyl)-3-Cyclohexyl-1-Nitrosourea (an anticancer drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2',3,4,5,5'-Pentachlorobiphenyl (PCB-124): 2',3,4,5,5'-Pentachlorobiphenyl (PCB-124) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2',3,4-Trichlorobiphenyl (PCB-33): 2',3,4-Trichlorobiphenyl (PCB-33) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl (PCB209): 2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl (PCB209) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl (PCB206): 2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl (PCB206) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,5'-Octachlorobiphenyl (PCB206): 2,2',3,3',4,4',5,5'-Octachlorobiphenyl (PCB206) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,6'-Octachlorobiphenyl (PCB-196): 2,2',3,3',4,4',5,6'-Octachlorobiphenyl (PCB-196) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl (PCB207): 2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl (PCB207) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4',5,6-Octachlorobiphenyl: 2,2',3,3',4,4',5,6-Octachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,4'-Hexachlorobiphenyl (PCB-128): 2,2',3,3',4,4'-Hexachlorobiphenyl (PCB-128) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,5,6,6'-Octachlorobiphenyl: 2,2',3,3',4,5,6,6'-Octachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,5,6-Heptachlorobiphenyl: 2,2',3,3,4,5,6-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,5-Hexachlorobiphenyl (PCB-1209): 2,2',3,3',4,5-Hexachlorobiphenyl (PCB-1209) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4,6,6'-Heptachlorobiphenyl: 2,2',3,3',4,6,6'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',4-Pentachlorobiphenyl: 2,2',3,3',4-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',5,5',6,6'-Octachlorobiphenyl (PCB-202): 2,2',3,3',5,5',6,6'-Octachlorobiphenyl (PCB-202) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',5,5',6-Heptachlorobiphenyl: 2,2',3,3',5,5',6-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',5,6'-Hexachlorobiphenyl: 2,2',3,3',5,6'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',5,6,6'-Heptachlorobiphenyl: 2,2',3,3',5,6,6'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',5,6,6'-Hexachlorobiphenyl (PCB-134): 2,2',3,3',5,6,6'-Hexachlorobiphenyl (PCB-134) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',6,6-Hexachlorobiphenyl (PCB-136): 2,2',3,3',6,6-Hexachlorobiphenyl (PCB-136) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3',6-Pentachlorobiphenyl: 2,2',3,3',6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3'-Tetrachlorobiphenyl (PCB-40): 2,2',3,3'-Tetrachlorobiphenyl (PCB-40) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,3'5-Pentachlorobiphenyl (PCB-83): 2,2',3,3'5-Pentachlorobiphenyl (PCB-83) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB-187): 2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB-187) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4',6,6'-Heptachlorobiphenyl: 2,2',3,4',6,6'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4',6-Hexachlorobiphenyl: 2,2',3,4',6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',5,5',6-Octachlorobiphenyl: 2,2',3,4,4',5,5',6-Octachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB-180): 2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB-180) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',5,6,6'-Octachlorobiphenyl: 2,2',3,4,4',5,6,6'-Octachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',5,6-Heptachlorobiphenyl: 2,2',3,4,4',5,6-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',6,6'-Heptachlorobiphenyl: 2,2',3,4,4',6,6'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4',6-Hexachlorobiphenyl: 2,2',3,4,4',6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,4'-Pentachlorobiphenyl: 2,2',3,4,4'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5',6-Hextachlorobiphenyl: 2,2',3,4,5',6-Hextachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5'-Pentachlorobiphenyl (PCB-87): 2,2',3,4,5'-Pentachlorobiphenyl (PCB-87) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5,5'-Hexachlorobiphenyl: 2,2',3,4,5,5'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5,6'-Heptachlorobiphenyl (PCB-185): 2,2',3,4,5,6'-Heptachlorobiphenyl (PCB-185) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5,6,6'-Heptachlorobiphenyl: 2,2',3,4,5,6,6'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5,6-Hexachlorobiphenyl: 2,2',3,4,5,6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,5-Pentachlorobiphenyl: 2,2',3,4,5-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,6'-Pentachlorobiphenyl: 2,2',3,4,6'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4,6-Pentachlorobiphenyl (PCB-88): 2,2',3,4,6-Pentachlorobiphenyl (PCB-88) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,4-Tetrachlorobiphenyl: 2,2',3,4-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,5'-Tetrachlorobiphenyl (PCB-44): 2,2',3,5'-Tetrachlorobiphenyl (PCB-44) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,5,5'-Pentachlorobiphenyl: 2,2',3,5,5'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,5,6-Pentachlorobiphenyl: 2,2',3,5,6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,5-Tetrachlorobiphenyl: 2,2',3,5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,6,6'-Pentachlorobiphenyl: 2,2',3,6,6'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3,6-Tetrachlorobiphenyl: 2,2',3,6-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',3-Trichlorobiphenyl (PCB-16): 2,2',3-Trichlorobiphenyl (PCB-16) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4',5-Tetrabromobiphenyl: 2,2',4',5-Tetrabromobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB-153): 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB-153) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4',5,6'-Hexachlorobiphenyl: 2,2',4,4',5,6'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4',6,6'-Hexachlorobiphenyl (PCB-155): 2,2',4,4',6,6'-Hexachlorobiphenyl (PCB-155) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4',6-Pentachlorobiphenyl (PCB-100): 2,2',4,4',6-Pentachlorobiphenyl (PCB-100) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4',6-Pentachlorobiphenyl (PCB-99): 2,2',4,4',6-Pentachlorobiphenyl (PCB-99) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,4'-Tetrachlorobiphenyl (PCB-47): 2,2',4,4'-Tetrachlorobiphenyl (PCB-47) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,5'-Tetrachlorobiphenyl (PCB-49): 2,2',4,5'-Tetrachlorobiphenyl (PCB-49) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,5,5'-Pentachlorobiphenyl (PCB-101): 2,2',4,5,5'-Pentachlorobiphenyl (PCB-101) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,5,6'-Pentachlorobiphenyl: 2,2',4,5,6'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,5-Tetrachlorobiphenyl: 2,2',4,5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,6,6'-Pentachlorobiphenyl (PCB-104): 2,2',4,6,6'-Pentachlorobiphenyl (PCB-104) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,6-Tetrachlorobiphenyl (PCB-50): 2,2',4,6-Tetrachlorobiphenyl (PCB-50) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4,6-Tetrachlorobiphenyl (PCB-51): 2,2',4,6-Tetrachlorobiphenyl (PCB-51) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',4-Trichlorobiphenyl: 2,2',4-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',5,5'-Tetrachlorobiphenyl (PCB-52): 2,2',5,5'-Tetrachlorobiphenyl (PCB-52) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',5,6'-Tetrachlorobiphenyl (PCB-53): 2,2',5,6'-Tetrachlorobiphenyl (PCB-53) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',5-Trichlorobiphenyl (PCB-18): 2,2',5-Trichlorobiphenyl (PCB-18) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',6,6'-Tetrachlorobiphenyl (PCB-54): 2,2',6,6'-Tetrachlorobiphenyl (PCB-54) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2',6-Trichlorobiphenyl: 2,2',6-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,2'-Dichlorobiphenyl (PCB-4): 2,2'-Dichlorobiphenyl (PCB-4) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',3,5,6-Pentachlorobiphenyl (PCB-95): 2,3',3,5,6-Pentachlorobiphenyl (PCB-95) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4',5'-Tetraachlorobiphenyl: 2,3',4',5'-Tetraachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4',5-Tetrachlorobiphenyl (PCB-70): 2,3',4',5-Tetrachlorobiphenyl (PCB-70) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,4',5'-Pentachlorobiphenyl: 2,3,4,4',5-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,4',5,5'-Hexachlorobiphenyl: 2,3',4,4',5,5'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,4',5-Pentachlorobiphenyl (PCB-118): 2,3',4,4',5-Pentachlorobiphenyl (PCB-118) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,4',6-Pentachlorobiphenyl: 2,3,4,4',6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,4'-Tetrachlorobiphenyl (PCB-66): 2,3',4,4'-Tetrachlorobiphenyl (PCB-66) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,5',6-Pentachlorobiphenyl: 2,3,4',5,6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,5,5'-Pentachlorobiphenyl: 2,3',4,5,5'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,5-Tetrachlorobiphenyl: 2,3,4',5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4,6-Tetrachlorobiphenyl: 2,3,4,6-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',4-Trichlorobiphenyl: 2,3,4'-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',5',6-Tetrachlorobiphenyl: 2,3',5',6-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',5'-Trichlorobiphenyl: 2,3,5-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',5,5'-Tetrachlorobiphenyl: 2,3',5,5'-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',5-Trichlorobiphenyl (PCB-26): 2,3',5-Trichlorobiphenyl (PCB-26) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3',6-Trichlorobiphenyl: 2,3,6-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3'-Dichlorobiphenyl: 2,3'-Dichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4',5,5',6-Hexachlorobiphenyl: 2,3,3',4',5,5',6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4',5,5'-Hexachlorobiphenyl: 2,3,3',4',5,5'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4',6-Pentachlorobiphenyl (PCB-110): 2,3,3',4',6-Pentachlorobiphenyl (PCB-110) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',5'-Hexachlorobiphenyl: 2,3,3',4,4',5'-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',5,5',6-Octachlorobiphenyl: 2,3,3',4,4',5,5',6-Octachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',5,5'-Heptachlorobiphenyl: 2,3,3',4,4',5,5'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',5,6-Heptachlorobiphenyl: 2,3,3',4,4',5,6-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',5-Hexachlorobiphenyl (PCB-156): 2,3,3',4,4',5-Hexachlorobiphenyl (PCB-156) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4',6-Hexachlorobiphenyl: 2,3,3',4,4',6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,4-Pentachlorobiphenyl (PCB-105): 2,3,3',4,4-Pentachlorobiphenyl (PCB-105) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,5,5',6-Heptachlorobiphenyl: 2,3,3',4,5,5',6-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,5,5'-Heptachlorobiphenyl: 2,3,3',4,5,5'-Heptachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,5,6-Hexachlorobiphenyl: 2,3,3',4,5,6-Hexachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,5-Pentachlorobiphenyl: 2,3,3',4,5-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4,6-Pentachlorobiphenyl: 2,3,3',4,6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',4-Tetrachlorobiphenyl: 2,3,3',4-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',5,5'-Pentachlorobiphenyl: 2,3,3',5,5'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',5,6-Pentachlorobiphenyl: 2,3,3',5,6-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',5-Tetrachlorobiphenyl: 2,3,3',5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3',6-Tetrachlorobiphenyl: 2,3,3',6-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,3'-Trichlorobiphenyl (PCB-20): 2,3,3'-Trichlorobiphenyl (PCB-20) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,4,4'-Tetrachlorobiphenyl (PCB-60): 2,3,4,4'-Tetrachlorobiphenyl (PCB-60) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,4,5,6-Pentachlorobiphenyl (PCB-116): 2,3,4,5,6-Pentachlorobiphenyl (PCB-116) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,4,5-Tetrachlorobiphenyl (PCB-61): 2,3,4,5-Tetrachlorobiphenyl (PCB-61) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,4-Tetrachlorobiphenyl (PCB-21): 2,3,4-Tetrachlorobiphenyl (PCB-21) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,5,6-Tetrachlorobiphenyl (PCB-65): 2,3,5,6-Tetrachlorobiphenyl (PCB-65) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,3-Dichlorobiphenyl (PCB-5): 2,3-Dichlorobiphenyl (PCB-5) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4',5-Trichlorobiphenyl: 2,4',5-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4',5-Trichlorobiphenyl (PCB-31): 2,4',5-Trichlorobiphenyl (PCB-31) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4',6-Trichlorobiphenyl: 2,4',6-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4'-Dichlorobiphenyl (PCB-8): 2,4'-Dichlorobiphenyl (PCB-8) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4,4',5-Tetrachlorobiphenyl (PCB-74): 2,4,4',5-Tetrachlorobiphenyl (PCB-74) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4,4',6-Tetrachlorobiphenyl (PCB-75): 2,4,4',6-Tetrachlorobiphenyl (PCB-75) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4,4'-Trichlorobiphenyl (PCB-28): 2,4,4'-Trichlorobiphenyl (PCB-28) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4,5-Trichlorobiphenyl (PCB-29): 2,4,5-Trichlorobiphenyl (PCB-29) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4,6-Trichlorobiphenyl (PCB-30): 2,4,6-Trichlorobiphenyl (PCB-30) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,4-Dichlorobiphenyl (PCB-7): 2,4-Dichlorobiphenyl (PCB-7) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,5-Dichlorobiphenyl (PCB-9): 2,5-Dichlorobiphenyl (PCB-9) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2,6-Dichlorobiphenyl (PCB-10): 2,6-Dichlorobiphenyl (PCB-10) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 2-Chlorobiphenyl (PCB-1): 2-Chlorobiphenyl (PCB-1) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4,4',5,5'-Hexachlorobiphenyl (PCB-169): 3,3',4,4',5,5'-Hexachlorobiphenyl (PCB-169) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4,4',5-Pentachlorobiphenyl: 3,3',4,4',5-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4,4'-Tetrachlorobiphenyl (PCB-77): 3,3',4,4'-Tetrachlorobiphenyl (PCB-77) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4,5'-Tetrachlorobiphenyl: 3,3',4,5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4,5,5'-Pentachlorobiphenyl: 3,3',4,5,5'-Pentachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',4-Trichlorobiphenyl (PCB-35): 3,3',4-Trichlorobiphenyl (PCB-35)is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',5,5'-Tetrachlorobiphenyl (PCB-80): 3,3',5,5'-Tetrachlorobiphenyl (PCB-80) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3',5-Trichlorobiphenyl: 3,3',5-Trichlorobiphenyl@ is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,3'-Dichlorobiphenyl (PCB-11): 3,3'-Dichlorobiphenyl (PCB-11) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4',5-Trichlorobiphenyl: 3,4,5-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4'-Dichlorobiphenyl: 3,4'-Dichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4,4',5-Tetrachlorobiphenyl: 3,4,4',5-Tetrachlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4,4',5-Tetrachlorobiphenyl (PCB-81): 3,4,4',5-Tetrachlorobiphenyl (PCB-81) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4,4'-Trichlorobiphenyl: 3,4,4'-Trichlorobiphenyl is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4,4-Trichlorobiphenyl (PCB-37): 3,4,4-Trichlorobiphenyl (PCB-37) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,4-Dichlorobiphenyl (PCB-12): 3,4-Dichlorobiphenyl (PCB-12) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3,5-Dichlorobiphenyl (PCB-14): 3,5-Dichlorobiphenyl (PCB-14) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 3-Chlorobiphenyl (PCB-2): 3-Chlorobiphenyl (PCB-2) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 4,4'-Dichlorobiphenyl (PCB-15): 4,4'-Dichlorobiphenyl (PCB-15) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- 4-Chlorobiphenyl (PCB-3): 4-Chlorobiphenyl (PCB-3) is an industrial chemical which is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Acetazolamide: Acetazolamide (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Acetohydroxamic Acid: Acetohydroxamic Acid (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Acetylsalicylic Acid: Acetylsalicylic Acid (a pharmaceutical drug - aspirin) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Actinomycin D: Actinomycin D (a pharmaceutical drug - chemotherapy, antibiotic) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Adriamycin: Adriamycin (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Alkyl Lead Compounds: Alkyl Lead Compounds (used mainly as fuel additives and industrial solvent) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Alkyl Mercury Compounds: Alkyl Mercury Compounds is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- All-Trans Retinoic Acid: All-Trans Retinoic Acid (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Alprazolam: Alprazolam (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Amantadine Hydrochloride: Amantadine Hydrochloride (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Amikacin Sulfate: Amikacin Sulfate (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aminoglutethimide: Aminoglutethimide (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aminoglycosides: Aminoglycosides (pharmaceutical drugs) are a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aminopterin: Aminopterin (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Amiodarone Hydrochloride: Amiodarone Hydrochloride (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Amitraz: Amitraz (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Ammonium Copper Arsenate: Ammonium Copper Arsenate is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Amoxapine: Amoxapine (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Angiotensin Converting Enzyme (ACE) Inhibitors: Angiotensin Converting Enzyme (ACE) Inhibitors (a pharmaceutical drug) are a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Anisindione: Anisindione (a pharmaceutical drug) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor: Aroclor (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1016: Aroclor 1016 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1210: Aroclor 1210 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1216: Aroclor 1216 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1221: Aroclor 1221 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1231: Aroclor 1231 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1232: Aroclor 1232 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1240: Aroclor 1240 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1242: Aroclor 1242 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1248: Aroclor 1248 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1250: Aroclor 1250 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1252: Aroclor 1252 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1254: Aroclor 1254 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1260: Aroclor 1260 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1262: Aroclor 1016 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Aroclor 1268: Aroclor 1268 (an industruail chemical) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Arsenic: Arsenic is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Arsenic (trivalent): Arsenic (trivalent) is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.
  • Developmental toxicity -- Arsenic Acid: Arsenic Acid is a recognized developmental toxicant and exposure to it has the potential to negatively affect a developing baby. The severity and range of negative effects experienced can vary greatly depending on the chemical, the stage of pregnancy at which the exposure occurred and the duration, level and nature (e.g. inhalation, skin exposure, ingestion) of the exposure. Developmental toxicity can include such things as low birth weight, birth defects, fetal death and behavioral and psychological problems. Sometimes the effects may not manifest until the baby becomes older.

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise